Evaluating lightning hazards to building environments using explicit numerical solutions of Maxwell's equations

The objective here is to describe the lightning hazards to buildings and their internal environments using advanced formulations of Maxwell's Equations. The method described is the Three Dimensional Finite Difference Time Domain Solution. It can be used to solve for the lightning interaction with such structures in three dimensions with the inclusion of a considerable amount of detail. Special techniques were developed for including wire, plumbing, and rebar into the model. Some buildings have provisions for lightning protection in the form of air terminals connected to a ground counterpoise system. It is shown that fields and currents within these structures can be significantly high during a lightning strike. Time lapse video presentations were made showing the electric and magnetic field distributions on selected cross sections of the buildings during a simulated lightning strike

Modelling Nonlinear Optics in the CERN SPS

Nonlinear fields arising from eddy currents in the vac-uum chamber and remanent fields in the magnets of the CERN SPS vary with time and with the acceleration cycle. We describe a procedure of constructing a nonlinear op-tics model for the SPS, by considering sextupolar, octupo-lar, and decapolar field errors in the dipole and quadrupole magnets, respectively, whose strengths are adjusted so as to best reproduce the measured nonlinear chromaticities up to third order in the momentum deviation. Applying this procedure to SPS chromaticity measurements taken at 26 GeV/c, we have obtained a refined optics model. The tune shifts with the transverse amplitude predicted by this model are consistent with a direct measurement

Endogenizing Syndromes

African and African American StudiesGovernmen

Reducing the SPS Machine Impedance

The SPS as LHC Injector project has been working for some time to prepare the SPS for its role as final injector for the LHC. This included major work related to injection, acceleration, extraction and beam instrumentation for the LHC beams [1]. Measurements carried out with the high brightness LHC beam showed that a major improvement of the machine impedance would also be necessary [2]. In addition to removing all lepton related components (once LEP operation ended in 2000), the decision was made to shield the vacuum system pumping port cavities. These accidental cavities had been identified as having characteristic frequencies in the 1-1.5GHz range. Since the SPS vacuum system contains roughly 1000 of these cavities, they constitute a major fraction of the machine impedance. As removal of the ports and associated bellows is not possible, transition shields (PPS) had to be designed to insert within the pumping port cavities

Understanding the structure directing action of copper-polyamine complexes in the direct synthesis of Cu-SAPO-34 and Cu-SAPO-18 catalysts for the selective catalytic reduction of NO with NH3

This work has been supported by Johnson Matthey PLC, UK.Cu2+ cations complexed by linear polyamines have been studied as structure-directing agents (SDAs) for the direct synthesis of copper-containing microporous silicoaluminophosphate (SAPO) materials. The complexing ligands diethylenetriamine (DETA), N-(2-hydroxyethyl)ethylenediamine (HEEDA), triethylenetetramine (TETA), N,N′-bis(2-aminoethyl)-1,3-propanediamine (232), 1,2-bis(3-aminopropylamino)ethane (323), tetraethylenepentamine (TEPA) and pentaethylenehexamine (PEHA) have been investigated. For comparison, syntheses have been performed using the analogous nickel-polyamine complexes. Cu2+ and Ni2+ forms of both SAPO-18 and SAPO-34 materials have been prepared. While most polyamine complexes direct crystallisation to SAPO-34, SAPO-18 has been prepared with Cu2+(232), Ni2+(232) and Ni2+(TETA). The coordination geometry of the included metal complexes was studied by UV-visible and EPR spectroscopy and computer simulation. SAPO-18 is favoured by the smaller square planar complexes or octahedral species (with 2 water molecules) of 232 and TETA. Calcination leaves extra-framework Cu2+ and Ni2+ cations within SAPO-18 and SAPO-34 frameworks. In situ synchrotron IR spectroscopy of Ni-SAPO-18 has shown thermal template degradation occurs via nitrile intermediates. Rietveld structural analysis located extra-framework Cu2+ and Ni2+ cations released by calcination. In SAPO-34, Cu2+ and Ni2+ were located in the 8R window of the cha cage. A second site was found for Ni2+ at the centre of the six-membered rings (6Rs) of the double-six-ring (D6R) sub-units. In SAPO-18 both Cu2+ and Ni2+ cations were located only in the 6Rs of the D6R sub-units. Selected copper SAPO-18 and SAPO-34 samples were tested in the selective catalytic reduction of NO with ammonia (NH3-SCR); both showed high activity.PostprintPostprintPeer reviewe

Delayed administration of a matrix metalloproteinase inhibitor limits progressive brain injury after hypoxia-ischemia in the neonatal rat

<p>Abstract</p> <p>Background</p> <p>Hypoxia-ischemia (H-I) can produce widespread neurodegeneration and deep cerebral white matter injury in the neonate. Resident microglia and invading leukocytes promote lesion progression by releasing reactive oxygen species, proteases and other pro-inflammatory mediators. After injury, expression of the gelatin-degrading matrix metalloproteinases (MMPs), MMP-2 and MMP-9, are thought to result in the proteolysis of extracellular matrix (ECM), activation of cytokines/chemokines, and the loss of vascular integrity. Thus, therapies targeting ECM degradation and progressive neuroinflammation may be beneficial in reducing H-I – induced neuropathy. Minocycline has MMP-inhibitory properties and is both anti-inflammatory and neuroprotective. AG3340 (prinomastat) is an MMP inhibitor with high selectivity for the gelatinases. The purpose of this study was to determine whether these compounds could limit H-I – induced injury when administered at a delayed time point.</p> <p>Methods</p> <p>Sprague-Dawley rats were exposed to H-I at postnatal day 7 (P7), consisting of unilateral carotid artery ligation followed by 90 min exposure to 8% O₂. Minocycline, AG3340, or vehicle were administered once daily for 6 days, beginning 24 hours after insult. Animals were sacrificed at P14 for neurohistological assessments. Immunohistochemistry was performed to determine the degree of reactive astrogliosis and immune cell activation/recruitment. Neural injury was detected using the Fluoro-Jade stain, a marker that identifies degenerating cells.</p> <p>Results</p> <p>CD11b and glial fibrillary acidic protein (GFAP) immunopositive cells increased in ipsilateral cortex after treatment with vehicle alone, demonstrating microglia/macrophage recruitment and reactive astrogliosis, respectively. Fluoro-Jade staining was markedly increased throughout the fronto-parietal cortex, striatum and hippocampus. Treatment with minocycline or AG3340 inhibited microglia/macrophage recruitment, attenuated astrogliosis and reduced Fluoro-Jade staining when compared to vehicle alone.</p> <p>Conclusion</p> <p>The selective gelatinase inhibitor AG3340 showed equal efficacy in reducing neural injury and dampening neuroinflammation when compared to the anti-inflammatory compound minocycline. Thus, MMP-2 and MMP-9 may be viable therapeutic targets to treat neonatal brain injury.</p

LEP Operation and Performance with 100 GeV Colliding Beams

Luminosity production in LEP was extended to 101 GeV beam energy in 1999 and 104.4 GeV in 2000. The performance was continually optimised, resulting in 1999 peak and integrated luminosities higher than in any previous year of LEP operation. In particular, the beam-beam tune shift reached 0.083 per interaction point. This was achieved with the help of a faster luminosity monitoring, a new tune working point, a reduced design vertical dispersion and new dispersion and coupling optimisation tools. A higher beam rate from the injectors, a better injection efficiency, a faster ramp and a newly automated control of the horizontal damping partition number Jx maximised the time available for physics and thus contributed to the higher integrated luminosity

Loss of VGLUT3 Produces Circadian-Dependent Hyperdopaminergia and Ameliorates Motor Dysfunction and l-Dopa-Mediated Dyskinesias in a Model of Parkinson\u27s Disease.

UNLABELLED: The striatum is essential for many aspects of mammalian behavior, including motivation and movement, and is dysfunctional in motor disorders such as Parkinson\u27s disease. The vesicular glutamate transporter 3 (VGLUT3) is expressed by striatal cholinergic interneurons (CINs) and is thus well positioned to regulate dopamine (DA) signaling and locomotor activity, a canonical measure of basal ganglia output. We now report that VGLUT3 knock-out (KO) mice show circadian-dependent hyperlocomotor activity that is restricted to the waking cycle and is due to an increase in striatal DA synthesis, packaging, and release. Using a conditional VGLUT3 KO mouse, we show that deletion of the transporter from CINs, surprisingly, does not alter evoked DA release in the dorsal striatum or baseline locomotor activity. The mice do, however, display changes in rearing behavior and sensorimotor gating. Elevation of DA release in the global KO raised the possibility that motor deficits in a Parkinson\u27s disease model would be reduced. Remarkably, after a partial 6-hydroxydopamine (6-OHDA)-mediated DA depletion (∼70% in dorsal striatum), KO mice, in contrast to WT mice, showed normal motor behavior across the entire circadian cycle. l-3,4-dihydroxyphenylalanine-mediated dyskinesias were also significantly attenuated. These findings thus point to new mechanisms to regulate basal ganglia function and potentially treat Parkinson\u27s disease and related disorders. SIGNIFICANCE STATEMENT: Dopaminergic signaling is critical for both motor and cognitive functions in the mammalian nervous system. Impairments, such as those found in Parkinson\u27s disease patients, can lead to severe motor deficits. Vesicular glutamate transporter 3 (VGLUT3) loads glutamate into secretory vesicles for neurotransmission and is expressed by discrete neuron populations throughout the nervous system. Here, we report that the absence of VGLUT3 in mice leads to an upregulation of the midbrain dopamine system. Remarkably, in a Parkinson\u27s disease model, the mice show normal motor behavior. They also show fewer abnormal motor behaviors (dyskinesias) in response to l-3,4-dihydroxyphenylalanine, the principal treatment for Parkinson\u27s disease. The work thus suggests new avenues for the development of novel treatment strategies for Parkinson\u27s disease and potentially other basal-ganglia-related disorders

LEP Performance at 91.5 GeV

The 1997 LEP collider run was the first year of the LEP2 program devoted to stable high luminosity running. The good performance of the LEP superconducting RF system allowed to run at beam energies of 91.5 GeV. In addition to the to usual optimisation procedures to minimise the vertical beam emittances, the horizontal beam sizes were reduced by increasing the horizontal damping partition number and reducing the betatron function at the interaction points. Vertical beam-beam tune shifts in excess of 0.05 were achieved with total beam currents of 5 mA. The total integrated luminosity of 73 pb-1 is the highest ever recorded in a single year of LEP operation